ArticleCancer medicine2022

Splenomegaly in predicting the survival of patients with advanced primary liver cancer treated with immune checkpoint inhibitors.

Lu-Shan Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.